Orchid Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun' 24	Mar' 24	Dec' 23	Sep' 23	Jun' 23

Sales

244.41

217.10

220.59

198.76

182.92

Operating profit

33.25

28.92

35.92

23.70

22.14

Interest

3.47

3.45

3.54

3.80

5.55

Gross profit

37.55

38.36

39.81

28.08

18.48

EPS (Rs)

5.74

6.54

6.02

3.99

2.12

Other income

7.77

12.88

7.44

8.18

1.89

Stock adjustment

-2.52

-28.34

-13.68

4.47

-6.34

Raw material

152.77

156.47

135.62

117.86

118.41

Power and fuel

-

-

-

-

-

Employee expenses

21.37

17.57

18.66

17.19

16.22

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

39.53

42.49

44.07

35.53

32.49

Provisions made

-

-

-

-

-

Depreciation

8.44

8.40

9.27

7.84

7.71

Taxation

-

-3.23

-

-

-

Net profit / loss

29.10

33.19

30.55

20.24

10.78

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

50.72

50.72

50.72

50.72

50.72

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

13.60

13.32

16.28

11.92

12.10

GPM (%)

14.89

16.68

17.46

13.57

10.00

NPM (%)

11.54

14.43

13.40

9.78

5.83